Search research articles
Contact Us
Filters
Showing results (351-360 of 426) with videos related to
Page
of 43
Sort By:
Nature Biotechnology
|
January 19, 2023
Genome-scale metabolic reconstruction of 7,302 human microorganisms for personalized medicine
Almut Heinken, Johannes Hertel, Geeta Acharya, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 26, 2006
Pharmacokinetics and toxicity of weekly docetaxel in older patients
Arti Hurria, Mark T Fleming, Sharyn D Baker, et al.
AIDS (London, England)
|
April 10, 1999
A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006)
P Musoke, L A Guay, D Bagenda, et al.
Hormone Research
|
May 2, 2009
Genetics, gene expression and bioinformatics of the pituitary gland
Shannon W Davis, Mary Anne Potok, Michelle L Brinkmeier, et al.
Physical Review Letters
|
April 8, 2014
Two-color gauge theory with novel infrared behavior
T Appelquist, R C Brower, M I Buchoff, et al.
Journal of the American Veterinary Medical Association
|
April 1, 2020
Characteristics and long-term outcomes of dogs with gastroesophageal intussusception
Janet A Grimes, Jeremy T Fleming, Ameet Singh, et al.
Briefings in Bioinformatics
|
April 25, 2018
Community-driven roadmap for integrated disease maps
Marek Ostaszewski, Stephan Gebel, Inna Kuperstein, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
January 16, 2019
3D Cultures of Parkinson's Disease-Specific Dopaminergic Neurons for High Content Phenotyping and Drug Testing
Silvia Bolognin, Marie Fossépré, Xiaobing Qing, et al.
Cell Reports
|
November 14, 2019
Integrated Analyses of Microbiome and Longitudinal Metabolome Data Reveal Microbial-Host Interactions on Sulfur Metabolism in Parkinson's Disease
Johannes Hertel, Amy C Harms, Almut Heinken, et al.
Future Oncology (London, England)
|
May 24, 2022
Targeting <i>FGFR3</i> alterations with adjuvant infigratinib in invasive urothelial carcinoma: the phase III PROOF 302 trial
Sumanta K Pal, Diederik M Somford, Petros Grivas, et al.
Page
of 43
Search research articles
Search
Showing results (351-360 of 426) with videos related to
Sort By:
Page
of 43
Nature Biotechnology
|
January 19, 2023
Genome-scale metabolic reconstruction of 7,302 human microorganisms for personalized medicine
Almut Heinken, Johannes Hertel, Geeta Acharya, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 26, 2006
Pharmacokinetics and toxicity of weekly docetaxel in older patients
Arti Hurria, Mark T Fleming, Sharyn D Baker, et al.
AIDS (London, England)
|
April 10, 1999
A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006)
P Musoke, L A Guay, D Bagenda, et al.
Hormone Research
|
May 2, 2009
Genetics, gene expression and bioinformatics of the pituitary gland
Shannon W Davis, Mary Anne Potok, Michelle L Brinkmeier, et al.
Physical Review Letters
|
April 8, 2014
Two-color gauge theory with novel infrared behavior
T Appelquist, R C Brower, M I Buchoff, et al.
Journal of the American Veterinary Medical Association
|
April 1, 2020
Characteristics and long-term outcomes of dogs with gastroesophageal intussusception
Janet A Grimes, Jeremy T Fleming, Ameet Singh, et al.
Briefings in Bioinformatics
|
April 25, 2018
Community-driven roadmap for integrated disease maps
Marek Ostaszewski, Stephan Gebel, Inna Kuperstein, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
January 16, 2019
3D Cultures of Parkinson's Disease-Specific Dopaminergic Neurons for High Content Phenotyping and Drug Testing
Silvia Bolognin, Marie Fossépré, Xiaobing Qing, et al.
Cell Reports
|
November 14, 2019
Integrated Analyses of Microbiome and Longitudinal Metabolome Data Reveal Microbial-Host Interactions on Sulfur Metabolism in Parkinson's Disease
Johannes Hertel, Amy C Harms, Almut Heinken, et al.
Future Oncology (London, England)
|
May 24, 2022
Targeting <i>FGFR3</i> alterations with adjuvant infigratinib in invasive urothelial carcinoma: the phase III PROOF 302 trial
Sumanta K Pal, Diederik M Somford, Petros Grivas, et al.
Page
of 43